Higin Capital

Higin Capital is a Beijing-based venture capital firm that specializes in the healthcare and life sciences sectors. It serves as the investment arm of Higin Care, a prominent Chinese Contract Research Organization (CRO) that provides comprehensive clinical trial services. The firm focuses on investing in innovative companies across biotechnology, medical devices, and digital health, particularly those in the early to growth stages. By combining financial capital with the clinical and regulatory expertise of its parent organization, Higin Capital aims to accelerate the commercialization of medical breakthroughs in the Chinese market. The firm plays a significant role in the Chinese healthcare ecosystem by bridging the gap between innovative R&D and clinical commercialization. Its strategic approach involves providing "Capital + Clinical" value-added services to its portfolio companies.